Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare
MONTREAL, Jan. 2, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc.
(NYSE: VRX) (TSX: VRX) today announced members of its senior management team
will make a presentation at the 31(st) Annual J.P. Morgan Healthcare
Conference on Tuesday, January 8, 2013 at 4:30 p.m. PT. The conference will be
held at the Westin St. Francis in San Francisco, CA.
A live webcast and audio archive of the presentation will be available on the
company's Web site at www.valeant.com. Click on Investor Relations, and then
the link to Events and Presentations. Participants should allow approximately
five to ten minutes prior to the presentation's start time to visit the site
and download any streaming media software needed to listen to the Internet
About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is
a multinational specialty pharmaceutical company that develops, manufactures
and markets a broad range of pharmaceutical products primarily in the areas of
neurology, dermatology and branded generics. More information about Valeant
can be found at www.valeant.com.
Contact Information: Laurie W. Little 949-461-6002 email@example.com
PRN Photo Desk, firstname.lastname@example.org
SOURCE: Valeant Pharmaceuticals International, Inc.
To view this news release in HTML formatting, please use the following URL:
CO: Valeant Pharmaceuticals International, Inc.
NI: HEA MTC CONF SHOW
-0- Jan/02/2013 22:01 GMT
Press spacebar to pause and continue. Press esc to stop.